Search results for the GEO ID: GSE7964 |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM197170 | GPL570 |
|
SEG1_vehicle pretreated_acid pulsed
|
Derived from human esophageal cancer
|
Human esophageal cancer cell line SEG-1
|
Gene expression data from acid-pulsed cells pretreated with vehicle
|
Sample_geo_accession | GSM197170
| Sample_status | Public on Jul 30 2007
| Sample_submission_date | May 31 2007
| Sample_last_update_date | Jun 20 2007
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | Cells were pretreated with vehicle or HDAC-42 (1.6 uM) in DMEM phenol red-free medium containing 5% FBS for 24 hours. Cells were then rinsed and pulsed with serum-free acidified medium (pH 3.5) or vehicle for 20 mins in a humidified chamber (37C). Cells were rinsed again and replenished with serum-free media or HDAC-42 (1.6 uM) in serum-free media. Cells were harvested 6 hours post vehicle or acid exposure.
| Sample_growth_protocol_ch1 | SEG-1 esophageal adenocarcinoma cells were plated at 2 x 10^6 cells/T75 flask.
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed per the manufacterer's instructions.
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | The Ovation™ Biotin RNA Amplification and Labeling System (NuGen Technologies, Inc., San Carlos, CA) was used to prepare amplified, biotin-labeled cDNA from total RNA for following manufacturer’s instructions. Briefly, first strand cDNA was synthesized from 25 ng of total RNA using a unique first strand DNA/RNA chimeric primer and reverse transcriptase. Following double strand cDNA generation, amplification of cDNA was achieved by utilizing an isothermal DNA amplification process that involves repeated SPIA™ DNA/RNA primer binding, DNA duplication, strand displacement and RNA cleavage. The amplified SPIA™ cDNA was purified and subjected to a two-step fragmentation and labeling process. The fragmented/biotinylated cDNA content was measured in a ND-1000 spectrophotometer and the quality was analyzed on an RNA 6000 Nano LabChip (Agilent) using Agilent Bioanalyzer 2100.
| Sample_hyb_protocol | Following fragmentation, labeled cRNA was hybridized to the human genoma gene chip U133 2.0 Plus. Hybridization was allowed to continue for 16 hours at 45ºC followed by washing and staining of microarrays in a Fluidics Station 450 (Affymetrix Inc., USA).
| Sample_scan_protocol | GeneChips were scanned in a GeneChip Scanner 3000 (Affymetrix Inc., USA)
| Sample_data_processing | CEL files were generated from DAT files using GeneChip® Operating Software (GCOS) software (Affymetrix Inc., USA). The probe set signals were generated using the RMA algorithm in ArrayAssist 3.4 (Stratagene) and were used to determine differential gene expression by pair-wise comparisons. The genes that were altered by two-fold either ways were sorted and used for further interpretation of the microarray data.
| Sample_platform_id | GPL570
| Sample_contact_name | Laura,A,Kresty
| Sample_contact_email | kresty.1@osu.edu
| Sample_contact_department | Internal Medicine
| Sample_contact_institute | The Ohio State University
| Sample_contact_address | CCC Building, Rm 302B
| Sample_contact_city | Columbus
| Sample_contact_state | OH
| Sample_contact_zip/postal_code | 43201
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM197nnn/GSM197170/suppl/GSM197170.CEL.gz
| Sample_series_id | GSE7964
| Sample_data_row_count | 54675
| |
|
GSM197171 | GPL570 |
|
SEG1_HDAC42 pretreated_acid pulsed
|
Derived from human esophageal cancer
|
Human esophageal cancer cell line SEG-1
|
Gene expression data from acid-pulsed cells pretreated with HDAC-42
|
Sample_geo_accession | GSM197171
| Sample_status | Public on Jul 30 2007
| Sample_submission_date | May 31 2007
| Sample_last_update_date | Jun 20 2007
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | Cells were pretreated with vehicle or HDAC-42 (1.6 uM) in DMEM phenol red-free medium containing 5% FBS for 24 hours. Cells were then rinsed and pulsed with serum-free acidified medium (pH 3.5) or vehicle for 20 mins in a humidified chamber (37C). Cells were rinsed again and replenished with serum-free media or HDAC-42 (1.6 uM) in serum-free media. Cells were harvested 6 hours post vehicle or acid exposure.
| Sample_growth_protocol_ch1 | SEG-1 esophageal adenocarcinoma cells were plated at 2 x 10^6 cells/T75 flask.
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | Trizol extraction of total RNA was performed per the manufacterer's instructions.
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | The Ovation™ Biotin RNA Amplification and Labeling System (NuGen Technologies, Inc., San Carlos, CA) was used to prepare amplified, biotin-labeled cDNA from total RNA for following manufacturer’s instructions. Briefly, first strand cDNA was synthesized from 25 ng of total RNA using a unique first strand DNA/RNA chimeric primer and reverse transcriptase. Following double strand cDNA generation, amplification of cDNA was achieved by utilizing an isothermal DNA amplification process that involves repeated SPIA™ DNA/RNA primer binding, DNA duplication, strand displacement and RNA cleavage. The amplified SPIA™ cDNA was purified and subjected to a two-step fragmentation and labeling process. The fragmented/biotinylated cDNA content was measured in a ND-1000 spectrophotometer and the quality was analyzed on an RNA 6000 Nano LabChip (Agilent) using Agilent Bioanalyzer 2100.
| Sample_hyb_protocol | Following fragmentation, labeled cRNA was hybridized to the human genoma gene chip U133 2.0 Plus. Hybridization was allowed to continue for 16 hours at 45ºC followed by washing and staining of microarrays in a Fluidics Station 450 (Affymetrix Inc., USA).
| Sample_scan_protocol | GeneChips were scanned in a GeneChip Scanner 3000 (Affymetrix Inc., USA)
| Sample_data_processing | CEL files were generated from DAT files using GeneChip® Operating Software (GCOS) software (Affymetrix Inc., USA). The probe set signals were generated using the RMA algorithm in ArrayAssist 3.4 (Stratagene) and were used to determine differential gene expression by pair-wise comparisons. The genes that were altered by two-fold either ways were sorted and used for further interpretation of the microarray data.
| Sample_platform_id | GPL570
| Sample_contact_name | Laura,A,Kresty
| Sample_contact_email | kresty.1@osu.edu
| Sample_contact_department | Internal Medicine
| Sample_contact_institute | The Ohio State University
| Sample_contact_address | CCC Building, Rm 302B
| Sample_contact_city | Columbus
| Sample_contact_state | OH
| Sample_contact_zip/postal_code | 43201
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM197nnn/GSM197171/suppl/GSM197171.CEL.gz
| Sample_series_id | GSE7964
| Sample_data_row_count | 54675
| |
|
|
|
Make groups for comparisons |
(2 groups will be compared at a time) |
|
Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
Select expression type |
Transcripts profile based on; |
A. Differential status (Up/Down regulation) |
|
|
Regulation type |
|
Fold change |
|
p-value |
|
|
|
B. Absolute calls (Transcribed/Not-detected) |
|
|
Derive calls within/across groups |
Within groups |
|
|
Detection status |
|
Percentage detection |
|
|
Across groups |
|
|
Detection status |
First group: |
- |
Second group:
|
Percentage detection |
First group: |
- |
Second group:
|
|
|
|
Filter results by number of probes |
|
|